Shares set to fall; Fortescue says China and Fortescue are in lock step amid historic loan; Block returns to growth mode; QBE ...

The outrage machine fired up over American Eagle’s advertising slogan — but not over Margaret Sanger’s own words about “bad ...

Cardiol's CardiolRx did not have a significant impact on left ventricular extracellular volume (LV-ECV) in the Phase II ARCHER study.

An ambitious plan to test extreme physics close to a black hole would involve a space probe weighing only a few grams, ...

Shares little changed from Wednesday’s record; ASX hammered on monopoly chatter, costs hit; Domain to exit sharemarket after ...

Several former Florida stars, as well as professionals that now train in Gainesville, added national medals to their trophy ...

China's navy is expanding at a breakneck pace, prompting renewed concerns about maritime balance and U.S. naval dominance in ...

Difficult second album syndrome has rarely loomed so large for a television series as in the case of Netflix’s Wednesday – ...

Amex Platinum Card changes revealed! Ben Hedges breaks down what CEO Steve Squeri said about the card's refresh, rewards, and annual fees. Stay informed on personal finance!

Abivax, MapLight Therapeutics, Everest Medicines, and Soleno Therapeutics bagged the biggest biotech funding rounds overall ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Sobi® today announced that the Committee for Medicinal Products for Human Use ...

ZUNVEYL was approved in July 2024 by the U.S. Food and Drug Administration (FDA) for the treatment of mild-to-moderate dementia of the Alzheimer's type in adults. As a new generation of ...